UTHealth | Clinical Trials

Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Purpose

A prospective, non-interventional, natural history study to assess the occurrence of higher FNAIT risk across a broad population of different racial and ethnic characteristics and the occurrence of HPA-1a alloimmunization in these women.

Condition

Fetal and Neonatal Alloimmune Thrombocytopenia

Eligibility

Eligible Ages: Over 18 Years
Eligible Genders: Female
Accepts Healthy Volunteers: Yes

Inclusion Criteria

Pregnant women (≥ 18 years of age) who have provided informed consent for the study.

Exclusion Criteria

Participants with prior history of FNAIT

Study Design

Phase
Study Type: Observational
Observational Model: Cohort
Time Perspective: Prospective

Arm Groups

Arm	Description	Assigned Intervention
Pregnant women	Women with higher risk of FNAIT	Other: Clinical data collection Laboratory tests, Vital assessments, Maternal and fetal genotype testing, Antibodies Testing will be performed.

Recruiting Locations

The University of Texas Health Science Center at Houston
Houston, Texas 77030

More Details

Status: Recruiting
Sponsor: Rallybio IPA, LLC

Study Contact

Chief Medical Officer
(203) 859-3820
clinicaltrials@rallybio.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.